Sign up USA
Proactive Investors - Run By Investors For Investors

Aphria responds to talk that US tobacco giant Altria Group is looking to take a stake in the Canadian cannabis grower

At the same time, the Canadian cannabis grower doesn't deny that talks are happening
cannabis and money
Altria and Aphria's management have met on a number of occasions to discuss a strategic partnership, The Globe and Mail says

Aphria Inc (OTCMKTS:APHQF) is not shooting down Wednesday's report in The Globe and Mail that the US tobacco giant Altria Group Inc (NYSE:MO) is looking to acquire a minority stake in the Canadian cannabis grower.

In a press release, Aphria said that it engages in discussions with potential strategic partners and investors from time to time and "there is no agreement, understanding or arrangement in place with a potential investor at this time.” Aphria will advise investors “of any material changes, if and when they occur” in keeping with disclosure requirements.

Aphria shares shot up Wednesday, closing up 14% higher at $15.30 after The Globe and Mail published a report that said Altria had expressed an interest in acquiring a minority stake with the intention of eventually holding a majority of the company’s shares.

READ: Tobacco powerhouse Altria in talks to acquire equity stake in Canadian cannabis grower Aphria, says The Globe and Mail

Altria and Aphria’s management have met on a number of occasions, with the most recent talks arranged on Monday, G&M said, citing sources.

A number of US companies in related industries are looking to orchestrate deals with Canadian cannabis companies given that recreational marijuana will be legal across Canada, beginning on October 17.

Chatter about Altria’s interest in Aphria follows on the heels of Constellation Brands Inc, the prominent US wine, liquor and beer company, (NYSE:STZ) making a $4 billion investment in Canadian cannabis company Canopy Growth Corp, which brings its stake in the company to 38%.

Altria shares were flat at $63.23 in Thursday's morning trading session while Aphria shares closed up 14% at $15.30 on Wednesday.

Contact Ellen Kelleher at [email protected]

View full APH profile View Profile

Aphria Timeline

Related Articles

scientist in lab
August 31 2018
While the data bodes well for MTD201, Midatech is most excited by the validation of its Q-Sphera sustained release technology, which it is using in some of its other compounds
Vial of pills
June 25 2018
Cosmos is a modern company, but the trade routes it relies on are ancient
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use